期刊文献+

抗磷脂抗体谱的临床应用和规范检测 被引量:7

Clinical application and standardization of antiphosphoUpid antibodies tests
原文传递
导出
摘要 抗磷脂综合征(APS)诊断标准明确将抗磷脂抗体(aPLs)的检测纳入其诊断标准,说明aPLs的检测对于APS的诊断意义重大。在过去的十几年中,对于如何提高aPLs的检测水平,如何实现aPLs的标准化进行了大量的工作。然而由于aPLs存在显著的异质性,aPLs的检测方法标准化程度较低以及不同实验室间检测结果一致性较差,一定程度限制了aPLs检测以及其临床应用。本文着重讨论aPLs的临床应用与检测规范,探讨如何建立aPLs检测的标准化体系以更好地提高aPLs的临昧捡泓。 According to the consensus criteria of antiphospholipid syndrome( APS), the diagnosis of APS requires the persistent presence of antiphospholipid antibodies (aPLs), indicating the critical role of aPLs in the diagnosis of APS. During the last decade, great efforts have been made to improve the laboratory detection and standardization of aPLs testing. Unfortunately, the heterogeneous nature of aPLs, lacking of standardization in aPLs test, and significant inter-laboratory variation have hampered the clinical application of aPLs test. In this commentary, the clinical application and standardization of aPLs test are focused on, and how to establish the standardization system in aPLs test in order to improve the performance of aPLs test in clinical practice are discussed.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2015年第12期793-796,共4页 Chinese Journal of Laboratory Medicine
关键词 抗磷脂综合征 抗体 抗磷脂 参考标准 Antiphospholipid syndrome Antibodies, antiphospholipid Reference standards
  • 相关文献

参考文献11

  • 1Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antipbospholipid syndrome ( APS ) [ J ]. J Thromb Haemost, 2006, 4(2): 295-306.
  • 2Persijn L, Decavele AS, Schouwers S, et al. Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome ~ J I. Thromb Res, 2011, 128 (6) : 565-569.
  • 3Hughes GRV, Harris EN, Gharavi AE. The anticardiolipin syndrome[J]. J Rheumatol, 1985, 13 : 486-489.
  • 4Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop [J]. Arthritis Rheum, 1999, 42(7) : 1309-131l.
  • 5Cervera R, Conti F, Doria A, et al. Does seronegative antiphospholipid syndrome really exist?[J]. Autoimmun Rev, 2012, 11(8) : 581-584.
  • 6Opatrny L, David M, Kahn SR, et al. Association between antiphospholipid antibodies and recmTent fetal loss in women without autoimmune disease : a metaanalysis [ J ]. J Rheumatol, 2006, 33(11) : 2214-2221.
  • 7张蜀澜,吴子燕,陈思,李媛,张文,李永哲.不同亚型抗磷脂抗体在系统性红斑狼疮诊断中的价值[J].中华检验医学杂志,2014,37(8):597-602. 被引量:14
  • 8Biggioggero M, Meroni PL. Meroni, the geoepidemiology of the antiphospholipid antibody syndrome[J]. Autoimmun Rev, 2010, 9(5) : A299-A304.
  • 9Salobir B, Sabovic M, Hojnik M, et al. Anti-beta 2-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease [ J]. Immunobiology, 2007, 212(3) : 193-199.
  • 10Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis [J]. J Thromb Haemost, 2009, 7 (10) : 1737-1740.

二级参考文献9

  • 1Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) [J]. J Thromb Haemost, 2006, 4: 295-306.
  • 2Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus[ J]. Arthritis Rheum, 1997, 40 : 1725.
  • 3Galli M, Luciani D, Bertolini G, et al. Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome[J]. Blood, 2003, 102: 2717-2723.
  • 4Salobir B, Sabovic M, Hojnik M, et al. Anti-beta 2-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease [ J ]. lmmunobiology, 2007, 212 : 193-199.
  • 5Ota K, Dambaeva S, Lee J, et al. Persistent high levels of IgM antiphospholipid antibodies in a patient with recurrent pregnancy losses and rheumatoid arthritis[ J]. Am J Reprod Immunol, 2014, 71 : 286-292.
  • 6Pengo V, Ruffatti A, Legnani C, et al. Clinical course of high- risk patients diagnosed with antiphospholipid syndrome [ J ]. J Thromb Haemost, 2010, 8: 237-242.
  • 7Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/ Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis [J]. J Thromb Haemost, 2009, 7: 1737-1740.
  • 8Opatrny L, David M, Kahn SR, et al. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease : a metaanalysis [ J ]. J Rheumatol, 2006, 33 : 2214-2221.
  • 9Ruiz-Garcia R, Serrano M, Martinez-Flores JA, et al. Isolated IgA anti- 132 glycoprotein I antibodies in patients with clinical criteria for antiphospholipid syndrome[J]. J Immunol Res, 2014, 2014 : 704395.

共引文献13

同被引文献40

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部